Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine
Gemma Navarro(Instituto de Salud Carlos III), Peter J. McCormick(Queen Mary University of London), Carme Lluı́s(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Vicent Casadó(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), David Moreno‐Delgado(Galapagos (Belgium)), Enric I. Canela(Biomedical Research Networking Center on Neurodegenerative Diseases), Josefa Mallol(Biomedical Research Networking Center on Neurodegenerative Diseases), Adam Sierakowiak(National Institute on Drug Abuse), Estefanía Moreno(Institute for Research in Biomedicine), Felix Hausch(Technische Universität Darmstadt), David Aguinaga(Biomedical Research Networking Center on Neurodegenerative Diseases), Antonio Cortés(Universitat de Barcelona), Kimberly A. McDowell(National Institute on Drug Abuse), Lesley A. Howell(Queen Mary University of London), César Quiroz(National Institutes of Health), Sergi Ferré(National Institute on Drug Abuse), William Rea(National Institute on Drug Abuse), Ning-Sheng Cai(National Institute on Drug Abuse)
Cited by 74
Related Papers
Striatal Adenosine A2A and Cannabinoid CB1 Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of Cannabinoids
|Neuropsychopharmacology|2007|249
Identification of Dopamine D1–D3 Receptor Heteromers
|Journal of Biological Chemistry|2008|230
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
|PLoS Biology|2015|212